Survey of Alberta doctors suggests concerns about anti-Indigenous biases in health care
The Metis Nation of Alberta says many of its members have experienced racism when accessing Alberta's hea...
Read moreResearch & Access Updates
B.C. announces new $440 million, 10-year cancer care action planB.C. announces new $440 million, 10-year cancer care action plan
A massive $440 million, 10-year investment into a new cancer action plan was announced by the B.C. govern...
Read moreRevolutionary CAR T Therapy Now Available for Patients with Specific Cancers in Saskatchewan
Saskatchewan patients with specific cancers can now receive an innovative type of immunotherapy closer to...
Read moreNatco Pharma (Canada) Inc. announces the launch of PrNAT-POMALIDOMIDE Capsules, the first generic alternative to POMALYST® in Canada
Natco Pharma (Canada) Inc., a subsidiary of Natco Pharma Limited, announced today the launch of PrNAT-POM...
Read moreAnnouncing the 3rd Canadian consensus manuscript: First Line Treatment of Newly Diagnosed Transplant Ineligible Multiple Myeloma
To address the needs of physicians and people diagnosed with multiple myeloma, Myeloma Canada has been le...
Read moreMyeloma research at the 64th American Society of Hematology (ASH) Annual Meeting and Exposition
Myeloma Canada, along with thousands from the global hematology community, had the privilege of attending...
Read more